Product Information
BUPRENORPHINE 7.5 MCG/HR PATCH is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $37.8502 per EA under NDC 00093323940. Its NADAC has been published 217 times since Jun 29, 2022.
FDA first approved this application on Nov 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 ug/h
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093323940
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA204937FDA Approved
11/20/2018
TE Code
AB
On Market Since
12/27/2021
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has been published 217 times since Jun 29, 2022, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.8502 per EA |
|---|---|
| All-time high | $62.8423 (Jan 11, 2023) |
| All-time low | $25.3493 (Nov 20, 2024) |
| 52-week high | $37.8502 |
| 52-week low | $30.1197 |
| Median price | $35.7557 |
| Average price | $39.7774 |
| Largest weekly change | +34.4% (Dec 21, 2022) |
| Weeks tracked | 217 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 7.5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 7.5 MCG/HR PATCH, manufactured by Teva Pharmaceuticals USA Inc., is $37.8502 per EA (NDC 00093323940), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 7.5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has declined 24.2%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 7.5 MCG/HR PATCH?
Since Jun 29, 2022, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has ranged from a low of $25.3493 (Nov 20, 2024) to a high of $62.8423 (Jan 11, 2023), with a median of $35.7557 per EA.
Are there cheaper alternatives to BUPRENORPHINE 7.5 MCG/HR PATCH?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 7.5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 7.5 MCG/HR PATCH?
BUPRENORPHINE 7.5 MCG/HR PATCH (NDC 00093323940) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.